Second Report Documents Industrys Intense Lobby and Political
Contribution Campaign to Keep Prices and Profits High

 WASHINGTON, D.C. - The pharmaceutical industry spends about one-fifth
of what it says it spends on the research and development (R&D) of new
{*filter*}, destroying the chief argument it uses against making
prescription {*filter*} affordable to middle and low-income seniors, a
Public Citizen investigation has found....
-----------------------

Also from that page:
Rx R&D Myths: The Case Against
The Drug Industrys R&D "Scare Card"
http://www.***.com/ {*filter*}/R&Dscarecard.html

The Other Drug War:
Big Pharmas 625 Washington Lobbyists
http://www.***.com/ {*filter*}/pharmadrugwar.html

I wonder what they do with the rest of the money if they are only
using 1/5th on research they did YEARS ago on interferon, ribavirin
and Thalidamyde?

Its awfully frustrating to try and educate people and enlighten them
as to what really is happening.

Interferon was researched for 30 years before it was approved for
cancer in the late 80's. (Where Gutterman takes full credit) ribavirin
was started for usage in young children and infants as an inhalent for
respitory virus's. WHAT IS LEFT TO STUDY IS THE VIRUS OF HEP C. That
they did create themselves.

Kim

Kim

Bla bla bla bla bla
Close your mouth i think u have the runs

Robin

U.S. House Backs Limited Drug Import Plan
http://www.***.com/

Gutknecht Prescription Drug Importation Amendment Passes
Overwhelmingly
http://www.***.com/

The House passed an amendment (H. Amdt. 150), part of an
appropriations bill (H.R. 2330), allowing limited importation of
prescription {*filter*}.  The bill has been referred to the Senate.  It's
got to pass both houses to become law.

http://www.***.com/ :HZ00150:
-------------------------------------

According to this page, that's as far as H.R. 2330 has gone.

Status of FY2002 Appropriations Bills
Last update: 07/25/2001 09:01:49
http://www.***.com/
---------------------------------------

There's a link on Rep. Gutknecht's site to a CNN story,

Prescription {*filter*} are crossing borders to buyers
http://www.***.com/ {*filter*}/index.html

that leads to a Canadian site that sells some RXs by mail to USA.

http://www.***.com/ {*filter*}tore.com/

Robin

Come to Thailand with me U can get all the {*filter*} u want.
They never heard of scrips. so its walk in ask want u want and walk out :)

If someone had the kind of cash $$ for the  airfare  it takes to fly to
Thailand, dont you think they could figure out a way to buy the meds
right out of Texas from Mexico??? Who's got $5000 to go to Thailand?

Oregon Doctor Doles Out
Pot Prescriptions
By Jonathan Serrie
http://www.***.com/ ,2933,30380,00.html
7-25-1

The jovial 78-year-old osteopath has approved more than 900 requests to
grow medical {*filter*}, which is allowed by the Oregon Medical {*filter*}
Act of 1999. The law allows patients suffering from severe pain, seizures
and other chronic conditions to grow their own {*filter*} with physician
approval.

Roughly 2,200 Oregonians have obtained permits to grow {*filter*} since the
law went into effect. And more than 40 percent of those patients were
approved by a single physician: Dr. Leveque.

"I have signed over 900 [applications to grow {*filter*}] now," Dr. Leveque
said. "The next person signed 71."

With his prolific approvals, Dr. Leveque has developed a reputation as the
"go to" physician for patients seeking medical {*filter*}. He receives
referrals from advocacy groups and even hosts his own TV show on public
access cable.

But Dr. Leveque's high profile has drawn sharp criticism from anti-drug
advocates.

"The biggest concern about what Dr. Leveque might be doing is
over-prescribing," said David Westbrook, who directs a help line for the
drug abuse prevention group Oregon Partnership.

Such concerns have prompted the Oregon Board of Medical Examiners to
investigate Dr. Leveque's practice.

"I deny vociferously that I am lenient," said Dr. Leveque. "I am going
exactly by the law of the Oregon Medical {*filter*} Act."

Dr. Leveque said the problem is not that he is too indulgent, but that
other doctors are too strict. Less than 550 of the state's 7,000 doctors
have signed any patient application forms to grow medical {*filter*}.

"They're afraid of George W. Bush and the DEA [Drug Enforcement
Administration]," Dr. Leveque said. "They're also afraid of the Oregon
Board of Medical Examiners in this particular state."

But the doctor's critics say there are plenty of good reasons to be
cautious. Because patients grow their own {*filter*}, the drug can vary in
potency and there is no recommended dosage. The thought of doctors
encouraging cancer patients to smoke creates an ironic twist.

"You see more tar coming from a joint or {*filter*} cigarette than you do
from a tobacco cigarette. So, this leads to bronchitis, asthma, and there
are carcinogens in it as well," Westbrook said.

Dr. Leveque insists he is following the mandate of Oregon's voters, who
approved the Medical {*filter*} Act in a 1998 referendum. But critics say
public opinion and medical expertise do not always go hand in hand.

Ultimately, Dr. Leveque's peers will decide whether what he is doing is
public service or reefer madness.

For release: September 5, 2001
Dorgan to Renew Effort to Allow US Access to Lower Priced
Prescription {*filter*} from Canada
http://www.***.com/ ~dorgan/press/01/06/2001905B06.html

(WASHINGTON, D.C.) - U.S. Senator Byron Dorgan (D-ND) said
Wednesday he will renew his efforts to allow U.S. senior citizens and
others to access lower priced prescription medicine sold abroad, and
will now focus that effort on allowing U.S. access to lower priced
medicines sold in Canada.

The savings for consumers, if he succeeds, could be enormous.
According to a report prepared by Dr. Alan Sager, Co-Director of the
Health Reform Program at Boston University's School of Public Health,
and released at a hearing Dorgan chaired, North Dakotans could save
$81 million annually in prescription medicine costs if they gained
access to prescription {*filter*} sold in Canada at much lower prices in
the U.S. For all Americans, the savings would amount to $38.4 billion
a year.

Dorgan chaired a hearing by the U.S. Senate's Consumer Affairs
Subcommittee, where he asked the Department of Health and Human
Services (HHS) to defend its decision earlier this year that blocked
implementation of a new law Congress passed last year that would have
allowed such access.

Dorgan said he found the HHS testimony "contradictory. I was very
disappointed in what they had to say. There is no evidence at all that
re-importing prescription {*filter*} into the United States would creat any
additional risk. Their contention that consumers wouldn't save money
is simply not believable. Clearly, there is a cost savings. That's why
people are going to Canada every day to purchase lower priced
prescription medicines for their own personal use. U.S. pharmacists
who would gain access to those lower priced supplies would also
clearly save money. The explanation for their decision was simply not
very persuasive."

Dorgan said this time he intends to focus his effort on clearing the
way for U.S. access to prescription medicines from Canada. "Not even
the HHS argues there is a credible safety threat with prescription
{*filter*} from Canada," Dorgan said, "so that may be a way to quickly
accomplish this, to allow American senior citizens to start saving
money more quickly, and to demonstrate just how ridiculous the excuses
HHS is making on this matter really are.